<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=SSX2</id>
	<title>SSX2 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=SSX2"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=SSX2&amp;action=history"/>
	<updated>2026-06-10T12:20:11Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=SSX2&amp;diff=4533&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Protein SSX2 (Cancer/testis antigen 5.2) (CT5.2) (Synovial sarcoma, X breakpoint 2) (Tumor antigen HOM-MEL-40) [SSX2A]  ==Publications==  {{medline-entry |title=E...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=SSX2&amp;diff=4533&amp;oldid=prev"/>
		<updated>2021-04-29T19:22:33Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Protein SSX2 (Cancer/testis antigen 5.2) (CT5.2) (Synovial sarcoma, X breakpoint 2) (Tumor antigen HOM-MEL-40) [SSX2A]  ==Publications==  {{medline-entry |title=E...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Protein SSX2 (Cancer/testis antigen 5.2) (CT5.2) (Synovial sarcoma, X breakpoint 2) (Tumor antigen HOM-MEL-40) [SSX2A]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Ectopic expression of cancer/testis antigen [[SSX2]] induces DNA damage and promotes genomic instability.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25363656&lt;br /&gt;
|abstract=SSX cancer/testis antigens are frequently expressed in melanoma tumors and represent attractive targets for immunotherapy, but their role in melanoma tumorigenesis has remained elusive. Here, we investigated the cellular effects of [[SSX2]] expression. In A375 melanoma cells, [[SSX2]] expression resulted in an increased DNA content and enlargement of cell nuclei, suggestive of replication aberrations. The cells further displayed signs of DNA damage and genomic instability, associated with p53-mediated G1 cell cycle arrest and a late apoptotic response. These results suggest a model wherein [[SSX2]]-mediated replication stress translates into mitotic defects and genomic instability. Arrest of cell growth and induction of DNA double-strand breaks was also observed in MCF7 breast cancer cells in response to [[SSX2]] expression. Additionally, MCF7 cells with ectopic [[SSX2]] expression demonstrated typical signs of senescence (i.e. an irregular and enlarged cell shape, enhanced β-galactosidase activity and DNA double-strand breaks). Since replication defects, DNA damage and senescence are interconnected and well-documented effects of oncogene expression, we tested the oncogenic potential of [[SSX2]]. Importantly, knockdown of [[SSX2]] expression in melanoma cell lines demonstrated that [[SSX2]] supports the growth of melanoma cells. Our results reveal two important phenotypes of ectopic [[SSX2]] expression that may drive/support tumorigenesis: First, immediate induction of genomic instability, and second, long-term support of tumor cell growth.&lt;br /&gt;
|mesh-terms=* Cell Line, Tumor&lt;br /&gt;
* Cellular Senescence&lt;br /&gt;
* DNA Breaks, Double-Stranded&lt;br /&gt;
* G1 Phase Cell Cycle Checkpoints&lt;br /&gt;
* Gene Expression Regulation, Neoplastic&lt;br /&gt;
* Genomic Instability&lt;br /&gt;
* Humans&lt;br /&gt;
* Melanoma&lt;br /&gt;
* Neoplasm Proteins&lt;br /&gt;
* Repressor Proteins&lt;br /&gt;
* Tumor Suppressor Protein p53&lt;br /&gt;
|keywords=* Cancer/testis antigen&lt;br /&gt;
* Genomic instability&lt;br /&gt;
* Oncogene&lt;br /&gt;
* SSX2&lt;br /&gt;
* Senescence&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528659&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>